Front. Immunol.
Frontiers in Immunology
Front. Immunol.
1664-3224
Frontiers Media S.A.
10.3389/fimmu.2023.1352525
Immunology
Correction
Corrigendum: A TNFR2-specific TNF fusion protein with improved in vivo activity
Gamboa VargasJuan
1
2
†
WagnerJennifer
3
†
ShaikhHaroon
1
2
LangIsabell
3
MedlerJuliane
3
AnanyMohamed
3
4
SteinfattTim
1
Peña MoscaJosefina
1
2
HaackStephanie
1
DahlhoffJulia
1
Büttner-HeroldMaike
5
GrafCarolin
1
VieraEstibaliz Arellano
1
EinseleHermann
1
WajantHarald
3
*
‡
BeilhackAndreas
1
2
‡
1Interdisciplinary Center for Clinical Research Laboratory, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
2Graduate School of Life Sciences, Würzburg University, Würzburg, Germany
3Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
4Department of Microbial Biotechnology, Institute of Biotechnology, National Research Center, Giza, Egypt
5Department of Nephropathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Harald Wajant, harald.wajant@mail.uni-wuerzburg.de
†These authors have contributed equally to this work
‡These authors have contributed equally to this work
18
12
2023
2023
14
1352525
08
12
2023
12
12
2023
Copyright © 2023 Gamboa Vargas, Wagner, Shaikh, Lang, Medler, Anany, Steinfatt, Peña Mosca, Haack, Dahlhoff, Büttner-Herold, Graf, Viera, Einsele, Wajant and Beilhack
2023
Gamboa Vargas, Wagner, Shaikh, Lang, Medler, Anany, Steinfatt, Peña Mosca, Haack, Dahlhoff, Büttner-Herold, Graf, Viera, Einsele, Wajant and Beilhack
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Corrigendum on A TNFR2-specific TNF fusion protein with improved in vivo activity by Vargas JG, Wagner J, Shaikh H, Lang I, Medler J, Anany M, Steinfatt T, Mosca JP, Haack S, Dahlhoff J, Büttner-Herold M, Graf C, Viera EA, Einsele H, Wajant H and Beilhack A (2022) Front. Immunol. 13:888274. doi: 10.3389/fimmu.2022.888274
agonist
GvHD
regulatory T cells
serum retention
TNF
TNFR2
section-in-acceptance
Immunological Tolerance and Regulation
Incorrect Affiliation
In the published article, there was an error in affiliation “4”. Instead of “Department of Microbial Biotechnology, Institute of Biotechnology, Giza, Egypt”, it should be “Department of Microbial Biotechnology, Institute of Biotechnology, National Research Center, Giza, Egypt”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.